Background illustration for clinical trials search

Paid Clinical Trials Fayetteville

Discover 156 paid clinical trials in Fayetteville, Arkansas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia

for
Schizophrenia
Location: Rogers AR, Little Rock AR, Richardson TX, DeSoto TX,
Sponsor: MapLight Therapeutics

Sex: All

Age: 18 - 65

Code: NCT07459647

Phase 2, Recruiting

Double-blind, Placebo-controlled Study in Adults With Major Depressive Disorder

for
Major Depressive Disorder (MDD)
Location: Rogers AR, Oklahoma City OK, O'Fallon MO,
Sponsor: Supernus Pharmaceuticals, Inc.

Sex: All

Age: 18 - 70

Code: NCT07226661

Phase 2, Recruiting

Saruparib in Combination With Physician's Choice of ARPI in Patients With mHSPC Previously Treated With Docetaxel or 177Lu-PSMA Therapy Without Disease Progression and PSA ≥ 0.2 ng/mL (EvoPAR-PR05)

for
Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
Location: Springdale AR, Margate FL, Miami FL, Montreal
Sponsor: AstraZeneca

Sex: Male

Age: 18+

Code: NCT07711002

Phase 3, Recruiting

A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-2)

for
Bipolar Disorder Type I With Mania or Mania With Mixed Features
Location: Rogers AR, Little Rock AR, Richardson TX, St Louis MO,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18 - 65

Code: NCT06951711

Phase 3, Recruiting

Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations

for
Non-Small Cell Lung Cancer
Location: Springdale AR, Little Rock AR, Kansas City MO,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06357533

Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)

for
Breast Cancer
Location: Springdale AR, St Louis MO, Dallas TX, Des Moines IA,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06103864

Phase 3, Recruiting

BostonGene and Exigent Genomic INsight Study

for
Breast Cancer, Non-small Cell Lung Cancer, Melanoma, Sarcoma
Location: Rogers AR, Tulsa OK, Houston TX, Albuquerque NM,
Sponsor: BostonGene

Sex: All

Age: 18+

Code: NCT06272864

Recruiting

ADCE-T02, a Tissue Factor Targeted Antibody-Drug Conjugate, in Patients With Selected Advanced Solid Tumours

for
Advanced Solid Tumor, PDAC, HNSCC
Location: Rogers AR, St Louis MO, Houston TX, San Antonio TX,
Sponsor: Adcendo ApS

Sex: All

Age: 18+

Code: NCT06597721

Phase 1, Recruiting

Study to Assess Safety, Pharmacokinetics, and Treatment Effect of Cabtreo

for
Acne Vulgaris
Location: Rogers AR, Bryant AR, Oklahoma City OK, Louisville KY,
Sponsor: Bausch Health Americas, Inc.

Sex: All

Age: 9 - 11

Code: NCT07524946

Recruiting

Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia

for
Schizophrenia
Location: Rogers AR, Bentonville AR, Little Rock AR,
Sponsor: Reviva Pharmaceuticals

Sex: All

Age: 18 - 65

Code: NCT05184335

Phase 3, Recruiting
New

A Study to Assess the Safety, Tolerability and Pharmacokinetics of XEP527 in Patients With Stable Schizophrenia

for
Schizophrenia
Location: Bentonville AR
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18 - 65

Code: NCT07908680

Phase 1, Recruiting

Relapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia

for
Schizophrenia
Location: Bentonville AR, Little Rock AR, Richardson TX,
Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company

Sex: All

Age: 18 - 65

Code: NCT07686263

Phase 3, Recruiting

Multicenter Study to Assess the Efficacy and Safety of LB-102 in the Treatment of Adult Patients With BP1MDE.

for
Bipolar I Disorder
Location: Bentonville AR, Little Rock AR, Richardson TX,
Sponsor: LB Pharmaceuticals Inc.

Sex: All

Age: 18 - 65

Code: NCT07494305

Phase 2, Recruiting

Study to Evaluate LB-102 for the Treatment of Adult Patients With Acute Schizophrenia

for
Schizophrenia
Location: Bentonville AR, Little Rock AR, St Louis MO, Chicago IL,
Sponsor: LB Pharmaceuticals Inc.

Sex: All

Age: 18 - 65

Code: NCT07363577

Phase 3, Recruiting

Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures

for
Focal Seizure, Epilepsy, Focal Epilepsy
Location: Bentonville AR, Omaha NE, Nashville TN, Huntsville AL,
Sponsor: Rapport Therapeutics Inc.

Sex: All

Age: 18 - 70+

Code: NCT07594119

Phase 3, Recruiting

Study of ALTO-300 in MDD

for
Major Depressive Disorder
Location: Rogers AR, Plano TX, St Louis MO, Stephenville TX,
Sponsor: Alto Neuroscience

Sex: All

Age: 18 - 70

Code: NCT05922878

Phase 2, Recruiting

Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer

for
Anatomic Stage II Breast Cancer AJCC v8,
Location: Fort Smith AR, Little Rock AR, Jonesboro AR, Olathe KS,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06058377

Phase 3, Recruiting

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

for
Fallopian Tube Endometrioid Adenocarcinoma,
Location: Fort Smith AR, Branson MO, Joplin MO, Springfield MO,
Sponsor: NRG Oncology

Sex: All

Age: 18+

Code: NCT06580314

Phase 3, Recruiting

GEMINI-NSCLC: NSCLC Biomarker Study

for
Non-Small Cell Lung Cancer
Location: Fort Smith AR, Joplin MO, Springfield MO, Tulsa OK,
Sponsor: Tempus AI

Sex: All

Age: 18+

Code: NCT05236114

Recruiting

A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer

for
Pancreatic Cancer, Metastatic Pancreatic Cancer,
Location: Fort Smith AR, Springfield MO, Oklahoma City OK,
Sponsor: Astellas Pharma Global Development, Inc.

Sex: All

Age: 18+

Code: NCT07409272

Phase 3, Recruiting